NDC 70511-162 – Bortezomib
Bortezomib 2.5 mg/1 · Injection · Intravenous
Product NDC70511-162
Product details
- Brand name
- Bortezomib
- Generic name
- Bortezomib
- Labeler
- MAIA Pharmaceuticals, Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA215331
- Marketed since
- August 10, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Proteasome Inhibitor
Active ingredients
- Bortezomib 2.5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70511-162-02 | 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-162-02) | Aug 11, 2022 |
Other Bortezomib products
- 70511-161 Bortezomib 1 mg/1 · Injection · MAIA Pharmaceuticals, Inc.
- 63759-3032 Bortezomib 3.5 mg/1.4mL · Injection · Shilpa Medicare Limited
- 60505-6050 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp
- 83634-208 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Avenacy, LLC
- 68001-534 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-541 Bortezomib 3.5 mg/3.5mL · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 68001-540 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 31722-303 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Camber Pharmaceuticals, Inc.
- 43598-426 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Dr.Reddy's Laboratories, Inc.
- 55150-337 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 63323-821 Bortezomib 3.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Fresenius Kabi USA, LLC
- 68083-651 Bortezomib 2.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited